Clinical outcomes for special populations of patients treated with first-line bevacizumab-based therapy in an observational study (AVVA)
| Autor: | Jose Maria Garcia-Bueno, E. Pujol, O. Juan Vidal, Manuel Domine, J. de Castro, B. Rubio-Viqueira, Regina Garcia, S. Saura, María Sereno, M. Cobo |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Cancer Research
medicine.medical_specialty Special populations Bevacizumab business.industry First line macromolecular substances respiratory tract diseases Surgery carbohydrates (lipids) stomatognathic diseases Oncology Internal medicine otorhinolaryngologic diseases medicine Observational study In patient business medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 29:e18033-e18033 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2011.29.15_suppl.e18033 |
| Popis: | e18033 Background: More than 50% of cases of advanced NSCLC are diagnosed in patients (pts) older than 65 years. Furthermore, the majority of pts with NSCLC present at the time of the diagnosis one... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|